12 results on '"Alexander, James"'
Search Results
2. Progress Toward Poliomyelitis Eradication -- Afghanistan, January 2012-September 2013.
- Author
-
Alexander, James P.
- Subjects
- *
POLIOMYELITIS vaccines , *POLIO prevention , *VACCINATION , *POLIOVIRUS , *REPORTING of diseases , *PREVENTION of communicable diseases - Abstract
The article reports on the progress toward the eradication of polio in Afghanistan through vaccination between January 2012 to September 2013. It says that nine cases of indigenous wild poliovirus (WPV 1) were confirmed during the period. It adds that no WPV 1 cases have been reported from the main WPV reservoir, the Southern Region, since November 2012, while all 9 cases were in the Eastern Region and caused by the WPV that originated from Pakistan.
- Published
- 2013
3. Progress Toward Measles Elimination - South-East Asia Region, 2003-2020.
- Author
-
Khanal, Sudhir, Kassem, Ahmed M., Bahl, Sunil, Jayantha, Liyanage, Sangal, Lucky, Sharfuzzaman, Mohammad, Bose, Anindya Sekhar, Antoni, Sebastien, Datta, Deblina, Alexander Jr., James P., and Alexander, James P Jr
- Abstract
In 2013, member states of the World Health Organization (WHO) South-East Asia Region* (SEAR) adopted the goal of measles elimination and rubella and congenital rubella syndrome control† by 2020 (1). In 2014, to provide impetus toward achieving this goal, the Regional Director declared measles elimination and rubella control one of the Regional Flagship Priorities. In 2019, SEAR member states declared a revised goal of eliminating both measles and rubella§ by 2023 (2). The recommended strategies to achieve elimination include 1) achieving and maintaining ≥95% coverage with 2 doses of measles- and rubella-containing vaccine in every district through routine or supplementary immunization activities¶ (SIAs); 2) developing and sustaining a sensitive and timely case-based surveillance system that meets recommended performance indicators**; 3) developing and maintaining an accredited laboratory network; 4) achieving timely identification, investigation, and response to measles outbreaks; and 5) collaborating with other public health initiatives to achieve the preceding four strategies. This report updates a previous report and describes progress toward measles elimination in SEAR during 2003-2020 (3). In 2002, coverage with the first dose of a measles-containing vaccine in routine immunization (MCV1) was 70%, and only three countries in SEAR had added a second routine dose of measles-containing vaccine in routine immunization (MCV2). During 2003-2020, all countries introduced MCV2, and estimated coverage with MCV1 increased 35%, from 65% to 88%, and coverage with MCV2 increased 1,233% from 6% to 80%. Approximately 938 million persons were vaccinated in SIAs. Annual reported measles incidence declined by 92%, from 57.0 to 4.8 cases per 1 million population, and estimated deaths decreased by 97%; an estimated 9.3 million deaths were averted by measles vaccination. By 2020, five countries were verified as having achieved measles elimination. To achieve measles elimination in the region by 2023, additional efforts are urgently needed to strengthen routine immunization services and improve measles-containing vaccine (MCV) coverage, conduct periodic high-quality SIAs, and strengthen measles case-based surveillance and laboratory capacity. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
4. Progress Toward Regional Measles Elimination - Worldwide, 2000-2019.
- Author
-
Patel, Minal K., Goodson, James L., Alexander Jr., James P., Kretsinger, Katrina, Sodha, Samir V., Steulet, Claudia, Gacic-Dobo, Marta, Rota, Paul A., McFarland, Jeffrey, Menning, Lisa, Mulders, Mick N., Crowcroft, Natasha S., and Alexander, James P Jr
- Subjects
- *
RUBELLA , *MEASLES , *MEDICAL personnel , *COVID-19 , *MEASLES vaccines - Abstract
In 2010, the World Health Assembly (WHA) set the following three milestones for measles control to be achieved by 2015: 1) increase routine coverage with the first dose of measles-containing vaccine (MCV1) among children aged 1 year to ≥90% at the national level and to ≥80% in every district, 2) reduce global annual measles incidence to <5 cases per 1 million population, and 3) reduce global measles mortality by 95% from the 2000 estimate* (1). In 2012, WHA endorsed the Global Vaccine Action Plan,† with the objective of eliminating measles§ in five of the six World Health Organization (WHO) regions by 2020. This report describes progress toward WHA milestones and regional measles elimination during 2000-2019 and updates a previous report (2). During 2000-2010, estimated MCV1 coverage increased globally from 72% to 84% but has since plateaued at 84%-85%. All countries conducted measles surveillance; however, approximately half did not achieve the sensitivity indicator target of two or more discarded measles and rubella cases per 100,000 population. Annual reported measles incidence decreased 88%, from 145 to 18 cases per 1 million population during 2000-2016; the lowest incidence occurred in 2016, but by 2019 incidence had risen to 120 cases per 1 million population. During 2000-2019, the annual number of estimated measles deaths decreased 62%, from 539,000 to 207,500; an estimated 25.5 million measles deaths were averted. To drive progress toward the regional measles elimination targets, additional strategies are needed to help countries reach all children with 2 doses of measles-containing vaccine, identify and close immunity gaps, and improve surveillance. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
5. Progress Toward Measles Elimination - Eastern Mediterranean Region, 2013-2019.
- Author
-
Goodson, James L., Teleb, Nadia, Ashmony, Hossam, Musa, Nasrin, Ghoniem, Amany, Hassan, Quamrul, Waciqi, Abdul Shakoor, Mere, Mohammed Osama, Farid, Muhammad, Abdo Mukhtar, Hanan Elhag, Iqbal, Javed, Alexander Jr., James P., Mukhtar, Hanan Elhag Abdo, and Alexander, James P Jr
- Abstract
In 1997, during the 41st session of the Regional Committee for the Eastern Mediterranean, the 21 countries in the World Health Organization (WHO) Eastern Mediterranean Region* (EMR) passed a resolution to eliminate† measles (1). In 2015, this goal was included as a priority in the Eastern Mediterranean Vaccine Action Plan 2016-2020 (EMVAP) (2), endorsed at the 62nd session of the Regional Committee (3). To achieve this goal, the WHO Regional Office for the Eastern Mediterranean developed a four-pronged strategy: 1) achieve ≥95% vaccination coverage with the first dose of measles-containing vaccine (MCV1) among children in every district of each country through routine immunization services; 2) achieve ≥95% vaccination coverage with a second MCV dose (MCV2) in every district of each country either through implementation of a routine 2-dose vaccination schedule or through supplementary immunization activities§ (SIAs); 3) conduct high-quality, case-based surveillance in all countries; and 4) provide optimal measles clinical case management, including dietary supplementation with vitamin A (4). This report describes progress toward measles elimination in EMR during 2013-2019 and updates a previous report (5). Estimated MCV1 coverage increased from 79% in 2013 to 82% in 2018. MCV2 coverage increased from 59% in 2013 to 74% in 2018. In addition, during 2013-2019, approximately 326.4 million children received MCV during SIAs. Reported confirmed measles incidence increased from 33.5 per 1 million persons in 2013 to 91.2 in 2018, with large outbreaks occurring in Pakistan, Somalia, and Yemen; incidence decreased to 23.3 in 2019. In 2019, the rate of discarded nonmeasles cases¶ was 5.4 per 100,000 population. To achieve measles elimination in the EMR, increased visibility of efforts to achieve the measles elimination goal is critically needed, as are sustained and predictable investments to increase MCV1 and MCV2 coverage, conduct high-quality SIAs, and reach populations at risk for not accessing immunization services or living in areas with civil strife. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
6. Progress Toward Measles Elimination - Pakistan, 2000-2018.
- Author
-
Mere, Mohammed Osama, Goodson, James L., Chandio, Arshad K., Rana, Muhammad Suleman, Hasan, Quamrul, Teleb, Nadia, Alexander Jr., James P., and Alexander, James P Jr
- Subjects
- *
MEASLES , *VACCINATION , *MEASLES vaccines , *DISEASE eradication , *DISEASE incidence , *MEASLES prevention - Abstract
In 1997, the 21 countries in the World Health Organization (WHO) Eastern Mediterranean Region* (EMR) passed a resolution during the 41st session of the Regional Committee for the Eastern Mediterranean to eliminate measles† (1). In 2015, this goal was included as a priority in the Eastern Mediterranean Vaccine Action Plan 2016-2020 (2), approved at the 62nd session of the Regional Committee (3). To achieve measles elimination, the WHO Regional Office for the Eastern Mediterranean developed the following four-pronged strategy: 1) achieve ≥95% vaccination coverage with the first dose of measles-containing vaccine (MCV) among children in every district of each country through routine immunization services; 2) achieve ≥95% vaccination coverage with a second MCV dose in every district of each country either through implementation of a routine 2-dose vaccination schedule or through supplementary immunization activities (SIAs)§; 3) conduct high-quality, case-based measles surveillance in all countries; and 4) provide optimal measles clinical case management, including dietary supplementation with vitamin A (4). Pakistan, an EMR country with a population of approximately 200 million, accounts for nearly one third of the overall EMR population. This report describes progress and challenges toward measles elimination in Pakistan during 2000-2018. During the study period, estimated coverage with the first MCV dose (MCV1) increased from 57% in 2000 to 76% in 2017. The second MCV dose (MCV2) was introduced nationwide in 2009, and MCV2 coverage increased from 30% in 2009 to 45% in 2017. During 2000-2018, approximately 232.5 million children received doses of MCV during SIAs. Reported confirmed measles incidence increased from an average of 24.6 per 1 million persons during 2000-2009 to an average of 80.4 during 2010-2018, with peaks in 2013 (230.3) and 2018 (153.6). In 2017 and 2018, the rates of suspected cases discarded as nonmeasles after investigation were 2.1 and 1.5 per 100,000 population, reflecting underreporting of cases. To achieve measles elimination, additional efforts are needed to increase MCV1 and MCV2 coverage, develop strategies to identify and reach communities not accessing immunization services, and increase sensitivity of case-based measles surveillance in all districts. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
7. Progress Toward Measles Elimination - European Region, 2009-2018.
- Author
-
Zimmerman, Laura A., Muscat, Mark, Singh, Simarjit, Mamou, Myriam Ben, Jankovic, Dragan, Datta, Siddhartha, Alexander, James P., Goodson, James L., O'Connor, Patrick, and Ben Mamou, Myriam
- Subjects
- *
RUBELLA , *MEASLES , *MEDICAL personnel , *VACCINATION , *MEASLES vaccines , *RUBELLA vaccines - Abstract
In 2010, all 53 countries* in the World Health Organization (WHO) European Region (EUR) reconfirmed their commitment to eliminating measles and rubella and congenital rubella syndrome (1); this goal was included as a priority in the European Vaccine Action Plan 2015-2020 (2). The WHO-recommended elimination strategies in EUR include 1) achieving and maintaining ≥95% coverage with 2 doses of measles-containing vaccine (MCV) through routine immunization services; 2) providing measles and rubella vaccination opportunities, including supplementary immunization activities (SIAs), to populations susceptible to measles or rubella; 3) strengthening surveillance by conducting case investigations and confirming suspected cases and outbreaks with laboratory results; and 4) improving the availability and use of evidence for the benefits and risks associated with vaccination (3). This report updates a previous report (4) and describes progress toward measles elimination in EUR during 2009-2018. During 2009-2017, estimated regional coverage with the first MCV dose (MCV1) was 93%-95%, and coverage with the second dose (MCV2) increased from 73% to 90%. In 2017, 30 (57%) countries achieved ≥95% MCV1 coverage, and 15 (28%) achieved ≥95% coverage with both doses. During 2009-2018, >16 million persons were vaccinated during SIAs in 13 (24%) countries. Measles incidence declined to 5.8 per 1 million population in 2016, but increased to 89.5 in 2018, because of large outbreaks in several EUR countries. To achieve measles elimination in EUR, measures are needed to strengthen immunization programs by ensuring ≥95% 2-dose MCV coverage in every district of each country, offering supplemental measles vaccination to susceptible adults, maintaining high-quality surveillance for rapid case detection and confirmation, and ensuring effective outbreak preparedness and response. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
8. Progress Toward Regional Measles Elimination - Worldwide, 2000-2017.
- Author
-
Dabbagh, Alya, Steulet, Claudia, Dumolard, Laure, Mulders, Mick N., Kretsinger, Katrina, Laws, Rebecca L., Alexander, James P., Goodson, James L., and Rota, Paul A.
- Subjects
- *
MEASLES prevention , *IMMUNIZATION , *MEASLES vaccines , *VACCINATION , *MEASLES virus , *DISEASE incidence , *PUBLIC health - Abstract
In 2010, the World Health Assembly set three milestones for measles prevention to be achieved by 2015: 1) increase routine coverage with the first dose of measles-containing vaccine (MCV1) among children aged 1 year to ≥90% at the national level and to ≥80% in every district; 2) reduce global annual measles incidence to less than five cases per million population; and 3) reduce global measles mortality by 95% from the 2000 estimate (1).* In 2012, the World Health Assembly endorsed the Global Vaccine Action Plan (GVAP),† with the objective of eliminating measles§ in four of the six World Health Organization (WHO) regions by 2015 and in five regions by 2020. Countries in all six WHO regions have adopted goals for measles elimination by 2020. This report describes progress toward global measles control milestones and regional measles elimination goals during 2000-2017 and updates a previous report (2). During 2000-2017, estimated MCV1 coverage increased globally from 72% to 85%; annual reported measles incidence decreased 83%, from 145 to 25 cases per million population; and annual estimated measles deaths decreased 80%, from 545,174 to 109,638. During this period, measles vaccination prevented an estimated 21.1 million deaths. However, measles elimination milestones have not been met, and three regions are experiencing a large measles resurgence. To make further progress, case-based surveillance needs to be strengthened, and coverage with MCV1 and the second dose of measles-containing vaccine (MCV2) needs to increase; in addition, it will be important to maintain political commitment and ensure substantial, sustained investments to achieve global and regional measles elimination goals. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
9. Measles-Rubella Supplementary Immunization Activity Readiness Assessment - India, 2017-2018.
- Author
-
Gurnani, Vandana, Haldar, Pradeep, Khanal, Sudhir, Bhatnagar, Pankaj, Singh, Balwinder, Ahmed, Danish, Samiuddin, Mohammad, Kumar, Arun, Negi, Yashika, Gupta, Satish, Harvey, Pauline, Bahl, Sunil, Dabbagh, Alya, Alexander, James P., and Goodson, James L.
- Subjects
- *
IMMUNIZATION , *MEASLES prevention , *CONGENITAL rubella syndrome , *RUBELLA , *PREVENTIVE medicine , *PUBLIC health - Abstract
In 2013, during the 66th session of the Regional Committee of the World Health Organization (WHO) South-East Asia Region (SEAR), the 11 SEAR countries* adopted goals to eliminate measles and control rubella and congenital rubella syndrome by 2020† (1). To accelerate progress in India (2,3), a phased§ nationwide supplementary immunization activity (SIA)¶ using measles-rubella vaccine and targeting approximately 410 million children aged 9 months-14 years commenced in 2017 and will be completed by first quarter of 2019. To ensure a high-quality SIA, planning and preparation were monitored using a readiness assessment tool adapted from the WHO global field guide** (4) by the India Ministry of Health and Family Welfare. This report describes the results and experience gained from conducting SIA readiness assessments in 24 districts of three Indian states (Andhra Pradesh, Kerala, and Telangana) during the second phase of the SIA. In each selected area, assessments were conducted 4-6 weeks and 1-2 weeks before the scheduled SIA. At the first assessment, none of the states and districts were on track with preparations for the SIA. However, at the second assessment, two (67%) states and 21 (88%) districts were on track. The SIA readiness assessment identified several preparedness gaps; early assessment results were immediately communicated to authorities and led to necessary corrective actions to ensure high-quality SIA implementation. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
10. Progress Toward Measles Elimination - Nepal, 2007-2014.
- Author
-
Khanal, Sudhir, Ram Sedai, Tika, Ram Choudary, Ganga, Narain Giri, Jagat, Bohara, Rajendra, Pant, Rajendra, Gautam, Mukunda, Sharapov, Umid M., Goodson, James L., Alexander, James, Dabbagh, Alya, Strebel, Peter, Perry, Robert T., Bah, Sunil, Abeysinghe, Nihal, Thapa, Arun, Sedai, Tika Ram, Choudary, Ganga Ram, and Giri, Jagat Narain
- Subjects
- *
MEASLES , *MEASLES vaccines , *VACCINATION , *PUBLIC health , *MEASLES prevention , *PATIENTS , *THERAPEUTICS - Abstract
In 2013, the 66th session of the Regional Committee of the World Health Organization (WHO) South-East Asia Region (SEAR) established a goal to eliminate measles and to control rubella and congenital rubella syndrome (CRS) in SEAR by 2020. Current recommended measles elimination strategies in the region include 1) achieving and maintaining ≥95% coverage with 2 doses of measles-containing vaccine (MCV) in every district, delivered through the routine immunization program or through supplementary immunization activities (SIAs); 2) developing and sustaining a sensitive and timely measles case-based surveillance system that meets minimum recommended performance indicators; 3) developing and maintaining an accredited measles laboratory network; and 4) achieving timely identification, investigation, and response to measles outbreaks. In 2013, Nepal, one of the 11 SEAR member states, adopted a goal for national measles elimination by 2019. This report updates a previous report and summarizes progress toward measles elimination in Nepal during 2007-2014. During 2007-2014, estimated coverage with the first MCV dose (MCV1) increased from 81% to 88%. Approximately 3.9 and 9.7 million children were vaccinated in SIAs conducted in 2008 and 2014, respectively. Reported suspected measles incidence declined by 13% during 2007-2014, from 54 to 47 cases per 1 million population. However, in 2014, 81% of districts did not meet the measles case-based surveillance performance indicator target of ≥2 discarded non-measles cases per 100,000 population per year. To achieve and maintain measles elimination, additional measures are needed to strengthen routine immunization services to increase coverage with MCV1 and a recently introduced second dose of MCV (MCV2) to ≥95% in all districts, and to enhance sensitivity of measles case-based surveillance by adopting a more sensitive case definition, expanding case-based surveillance sites nationwide, and ensuring timely transport of specimens to the accredited national laboratory. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
11. Progress Toward Measles Elimination -- Eastern Mediterranean Region, 2008-2012.
- Author
-
Teleb, Nadia, Lebo, Emmaculate, Ahmed, Hinda, Hossam, Abdel Rahman, El Sayed, El Tayeb, Dabbagh, Alya, Strebel, Peter, Rota, Paul, and Alexander, James
- Subjects
- *
MEASLES prevention , *VACCINATION , *MEASLES vaccines - Abstract
The article reports developments in the efforts to eliminate measles in the Eastern Mediterranean Region (EMRO) in 2008-2012. It cites the four-pronged strategy to achieve said goal, including the vaccination of children with first and second doses of measles-containing vaccine (MCV1 & MCV2). It features such organizations as the World Health Organization (WHO) and the United Nations Children's Fund (UNICEF).
- Published
- 2014
12. Measles -- Horn of Africa, 2010-2011.
- Author
-
Kebede, Assegid, Ahmed, Hinda, Masresha, Balcha G., Perry, Robert T., Burton, Ann, Spiegel, Paul, Blanton, Curtis, Husain, Farah, Goodson, James L., and Alexander, James P.
- Subjects
- *
MEASLES , *EPIDEMICS , *MEASLES vaccines - Abstract
The article reports on measles outbreaks that occurred in the Horn of Africa, including Somalia, Kenya and Ethiopia, during 2010-2011 despite efforts of the World Health Organization (WHO) to achieve measles elimination goals. It outlines the number of reported measles cases in Kenya, Somalia and Ethiopia and the estimated measles-containing vaccine (MCV) coverage in each country. It relates the targets endorsed by the World Health Assembly for global measles eradication by 2015.
- Published
- 2012
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.